184 related articles for article (PubMed ID: 19106231)
41. Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice.
Okada N; Masunaga Y; Okada Y; Mizuguchi H; Iiyama S; Mori N; Sasaki A; Nakagawa S; Mayumi T; Hayakawa T; Fujita T; Yamamoto A
Gene Ther; 2003 Oct; 10(22):1891-902. PubMed ID: 14502218
[TBL] [Abstract][Full Text] [Related]
42. Inefficient cross-presentation limits the CD8+ T cell response to a subdominant tumor antigen epitope.
Otahal P; Hutchinson SC; Mylin LM; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2005 Jul; 175(2):700-12. PubMed ID: 16002665
[TBL] [Abstract][Full Text] [Related]
43. Imaging T Cell Dynamics and Function Using PET and Human Nuclear Reporter Genes.
Lee JT; Moroz MA; Ponomarev V
Methods Mol Biol; 2018; 1790():165-180. PubMed ID: 29858791
[TBL] [Abstract][Full Text] [Related]
44. IL-15 enhances the in vivo antitumor activity of tumor-reactive CD8+ T cells.
Klebanoff CA; Finkelstein SE; Surman DR; Lichtman MK; Gattinoni L; Theoret MR; Grewal N; Spiess PJ; Antony PA; Palmer DC; Tagaya Y; Rosenberg SA; Waldmann TA; Restifo NP
Proc Natl Acad Sci U S A; 2004 Feb; 101(7):1969-74. PubMed ID: 14762166
[TBL] [Abstract][Full Text] [Related]
45. T cell homing to tumors detected by 3D-coordinated positron emission tomography and magnetic resonance imaging.
Agger R; Petersen MS; Petersen CC; Hansen SB; Stødkilde-Jørgensen H; Skands U; Blankenstein T; Andersen TE; Hulgaard EF; Jørgensen JT; Marqversen J; Gundersen HJ; Hokland ME
J Immunother; 2007 Jan; 30(1):29-39. PubMed ID: 17198081
[TBL] [Abstract][Full Text] [Related]
46. Imaging of Sleeping Beauty-Modified CD19-Specific T Cells Expressing HSV1-Thymidine Kinase by Positron Emission Tomography.
Najjar AM; Manuri PR; Olivares S; Flores L; Mi T; Huls H; Shpall EJ; Champlin RE; Turkman N; Paolillo V; Roszik J; Rabinovich B; Lee DA; Alauddin M; Gelovani J; Cooper LJ
Mol Imaging Biol; 2016 Dec; 18(6):838-848. PubMed ID: 27246312
[TBL] [Abstract][Full Text] [Related]
47. Glucocorticoids do not inhibit antitumor activity of activated CD8+ T cells.
Hinrichs CS; Palmer DC; Rosenberg SA; Restifo NP
J Immunother; 2005; 28(6):517-24. PubMed ID: 16224268
[TBL] [Abstract][Full Text] [Related]
48. Noninvasive detection of therapeutic cytolytic T cells with 18F-FHBG PET in a patient with glioma.
Yaghoubi SS; Jensen MC; Satyamurthy N; Budhiraja S; Paik D; Czernin J; Gambhir SS
Nat Clin Pract Oncol; 2009 Jan; 6(1):53-8. PubMed ID: 19015650
[TBL] [Abstract][Full Text] [Related]
49. Reporter gene imaging of targeted T cell immunotherapy in recurrent glioma.
Keu KV; Witney TH; Yaghoubi S; Rosenberg J; Kurien A; Magnusson R; Williams J; Habte F; Wagner JR; Forman S; Brown C; Allen-Auerbach M; Czernin J; Tang W; Jensen MC; Badie B; Gambhir SS
Sci Transl Med; 2017 Jan; 9(373):. PubMed ID: 28100832
[TBL] [Abstract][Full Text] [Related]
50. In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma.
Linette GP; Shankara S; Longerich S; Yang S; Doll R; Nicolette C; Preffer FI; Roberts BL; Haluska FG
J Immunol; 2000 Mar; 164(6):3402-12. PubMed ID: 10706736
[TBL] [Abstract][Full Text] [Related]
51. CD8+ T cells targeting a single immunodominant epitope are sufficient for elimination of established SV40 T antigen-induced brain tumors.
Tatum AM; Mylin LM; Bender SJ; Fischer MA; Vigliotti BA; Tevethia MJ; Tevethia SS; Schell TD
J Immunol; 2008 Sep; 181(6):4406-17. PubMed ID: 18768900
[TBL] [Abstract][Full Text] [Related]
52. HSV-sr39TK positron emission tomography and suicide gene elimination of human hematopoietic stem cells and their progeny in humanized mice.
Gschweng EH; McCracken MN; Kaufman ML; Ho M; Hollis RP; Wang X; Saini N; Koya RC; Chodon T; Ribas A; Witte ON; Kohn DB
Cancer Res; 2014 Sep; 74(18):5173-83. PubMed ID: 25038231
[TBL] [Abstract][Full Text] [Related]
53. Adoptive transfer of ex vivo-activated memory T-cell subsets with cyclophosphamide provides effective tumor-specific chemoimmunotherapy of advanced metastatic murine melanoma and carcinoma.
Gold JE; Zachary DT; Osband ME
Int J Cancer; 1995 May; 61(4):580-6. PubMed ID: 7759164
[TBL] [Abstract][Full Text] [Related]
54. Antigen-Dependent Inducible T-Cell Reporter System for PET Imaging of Breast Cancer and Glioblastoma.
Shin J; Parker MFL; Zhu I; Alanizi A; Rodriguez CI; Liu R; Watchmaker PB; Kalita M; Blecha J; Luu J; Wright B; Lapi SE; Flavell RR; Okada H; Tlsty TD; Roybal KT; Wilson DM
J Nucl Med; 2023 Jan; 64(1):137-144. PubMed ID: 35981900
[TBL] [Abstract][Full Text] [Related]
55. Visualizing γδ T cells by very late antigen-4-targeted positron emission tomography.
Long Y; Lv X; Song X; Shao F; Ji H; Zhang Y; Qiao P; Liu Q; Xia X; Lei P; Gai Y; Lan X
Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4156-4170. PubMed ID: 35790537
[TBL] [Abstract][Full Text] [Related]
56. Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control.
Vianello F; Papeta N; Chen T; Kraft P; White N; Hart WK; Kircher MF; Swart E; Rhee S; Palù G; Irimia D; Toner M; Weissleder R; Poznansky MC
J Immunol; 2006 Mar; 176(5):2902-14. PubMed ID: 16493048
[TBL] [Abstract][Full Text] [Related]
57. Small-animal PET imaging analysis with [
Lee O; Kim J; Oh C
Exp Dermatol; 2018 Feb; 27(2):199-201. PubMed ID: 29197132
[TBL] [Abstract][Full Text] [Related]
58. Cytotoxic T cells reactive to an immunodominant leukemia-associated antigen can be specifically primed and expanded by combining a specific priming step with nonspecific large-scale expansion.
Ghosh A; Wolenski M; Klein C; Welte K; Blazar BR; Sauer MG
J Immunother; 2008; 31(2):121-31. PubMed ID: 18481382
[TBL] [Abstract][Full Text] [Related]
59. Inhibition of melanoma growth by targeting of antigen to dendritic cells via an anti-DEC-205 single-chain fragment variable molecule.
Johnson TS; Mahnke K; Storn V; Schönfeld K; Ring S; Nettelbeck DM; Haisma HJ; Le Gall F; Kontermann RE; Enk AH
Clin Cancer Res; 2008 Dec; 14(24):8169-77. PubMed ID: 19088032
[TBL] [Abstract][Full Text] [Related]
60. Potent selection of antigen loss variants of B16 melanoma following inflammatory killing of melanocytes in vivo.
Sanchez-Perez L; Kottke T; Diaz RM; Ahmed A; Thompson J; Chong H; Melcher A; Holmen S; Daniels G; Vile RG
Cancer Res; 2005 Mar; 65(5):2009-17. PubMed ID: 15753401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
